NZ dollar rides optimism on unproven covid-19 treatment

NZ dollar rides optimism on unproven covid-19 treatment
Jenny Ruth
The New Zealand dollar rode a wave of optimism about a still-unproven covid-19 treatment which has been driving equities markets higher. At the same time, the market has been ignoring worse than expected US March-quarter GDP data and a downbeat economic assessment from the Federal Reserve. The kiwi was trading at 61.44 US cents at 5pm in Wellington from 60.93 cents at the same time yesterday. The trade-weighted index was at 69.11 from 68.78. Biopharmaceutical company Gilead has been talking up Remdesivir, a drug which proved ineffectiv...

More Markets

Spark paving the way for margin-focused future
Markets

Spark paving the way for margin-focused future

The telco’s unexciting half-year results give a glimpse of its hopes for the future.

How Gentrack made its India expansion work
Markets

How Gentrack made its India expansion work

Gentrack boss on the importance of local leadership.

RBNZ rate call gives NZ stocks a boost
Markets Market close

RBNZ rate call gives NZ stocks a boost

The S&P/NZX50 index ended at 11,763.32, up 68.71 points or 0.59%.

Jamie Gray 28 Feb 2024
Skincare brand Me Today to sell King Honey as losses climb
Markets

Skincare brand Me Today to sell King Honey as losses climb

Former Trilogy CEO Stephen Sinclair will take the helm.

Gregor Thompson 28 Feb 2024